Dividend investing for retirement Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dividend investing for retirement

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John F. Poteraske	1/18/2008 12:55:08 AM
	Read Replies (2) of 34328

Pfizer's Low Price, High R&D a Proven Formula: smartmoney.com "There are eight molecules presently in so-called Phase III, or final, clinical trials. Four of these are new uses for existing medicines. The company is widely expected to use its cash stockpile to purchase developmental drugs or entire companies in the coming years. And the stock turned up recently in a search for big drug makers that spent more money on research and development over the past year than they had the year before, and that carry "price/R&D ratios" of below 20. Normally investors look for earnings growth and low price/earnings ratios to find promising stocks, but for drug and technology companies, research spending may be thought of as earnings that have yet to materialize. Studies have shown a strong link between stock performance and both low P/R&D ratios and increased R&D spending"

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next